| J2350 | Injection, ocrelizumab, 1 mg | 2 | 10 | 330 | $11,290 | $4M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 9 | 100 | 2,830 | $80 | $3.8M |
| J9271 | Injection, pembrolizumab, 1 mg | 3 | 10 | 270 | $3,820 | $2.9M |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 1 | 110 | 5,950 | $270 | $2.6M |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 4 | 10 | 1,290 | $1,830 | $2.4M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 8 | 230 | 5,440 | $90 | $1.8M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 7 | 230 | 6,220 | $100 | $1.8M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 2 | 190 | 5,130 | $100 | $1.8M |
| J2323 | Injection, natalizumab, 1 mg | 1 | 10 | 1,110 | $1,460 | $1.5M |
| 77412 | The provider delivers radiation therapy at level 3 complexity. This includes photon therapy delivered to multiple isocenters, photon therapy with active motion management, total skin electron… | 2 | 10 | 1,470 | $400 | $1.2M |